Back to Superinvestors
SUPERINVESTOR HOLDERS

RLAY

Relay Therapeutics Inc
Healthcare · Biotechnology
Holders
2
Total value
$30,468,940
Total shares
1,628,473
Cross-link
Financials →
Investor Shares Value % of Portfolio Activity As of
Cliff Asness
AQR Capital Management
1,279,473 $23,938,940 0.01% REDUCE -10,559 30 Jun 2026
Stanley Druckenmiller
Duquesne Family Office
349,000 $6,530,000 0.12% NEW +349,000 30 Jun 2026